Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

Neuroinflammation and immune-brain interactions

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (358)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

358 papers

SearchSort evidence

All358 Core191 Supporting183 Background0

Showing 181-192 of total 358 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Targeting S100A8/A9: a molecular gateway to oral inflammation, microglial activation and neuroinflammation.

Malik JA; Qamar T; Qadri AH; Faheem I

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

The Thyroid-Brain Network: Exploring Inflammation, Immune Mechanisms and Common Triggers in Thyroid-Related Neurological Dysfunction.

Ullah MF

Jan 1, 2026Neuroendocrinology

2026PubMedDirectly related

Adult primary whole-brain cultures from Thy1-aSyn mice (Line 61) retain Parkinson's disease-relevant phenotypes.

Zalpanow D; Merten A; Stelz S; Ofner A; Weiß S; Richter F; Lau K; Kotzur R

Jan 1, 2026Neuroscience

2026PubMedSupporting evidence

Microglia-derived extracellular vesicles uncover early alterations of inflammatory signaling in Alzheimer's disease.

Bianchessi C; Serpente M; Ferri E; Giudici G; Arcaro M; Borracci V; Visconte C; Buccellato F; Sacchi L; Pintus M; Arosio B; Arighi A; Fenoglio C; Galimberti D

Jan 1, 2026GeroScience

2026PubMedDirectly related

Microglia-targeted Panax notoginseng polysaccharide nanoparticles alleviate Alzheimer's disease via AMPK-mTOR/HIF-1α-mediated immunometabolic reprogramming.

Zhang G; Kong L; Guo RB; Ding SW; Liu Y; Zang J; Zheng Y; Wei B; Chen ZC; Yang Y; Li XT; Yu Y

Jan 1, 2026Materials today. Bio

2026PubMedSupporting evidence

Physical Training in Parkinson's Disease: A Systematic Review of Neurobiological Mechanisms, Brain-Muscle Adaptations, and Implications for Personalized Rehabilitation.

Jannou A; Welter ML

Jan 1, 2026Neuro-degenerative diseases

2026PubMedDirectly related

Mitochondrial Crossroads in Neurobiology: From Cellular Vulnerability to Therapeutic Opportunity.

Valenzuela R; Rodríguez-Pérez AI

Jan 1, 2026Cellular and molecular neurobiology

2026PubMedDirectly related

A Systematic Review of the Vascular and Neuronal Role of L-Carnosine: Mechanistic and Pharmacological Perspectives.

Tiwari N; Kumar V; Joshi BC; Saeedan AS; Rashid S; Ansari MN

Jan 1, 2026Current neuropharmacology

2026PubMedSupporting evidence

Postbiotics as a Therapeutic Target in Cognitive Impairment: Exploring into Molecular Pathways and Neuroprotective Effects.

Dipa P; Neha; Mandal S; Aran KR

Jan 1, 2026Ageing research reviews

2026PubMedDirectly related

Enhanced neuroprotective effects of combined photobiomodulation and hydrogen inhalation in a mouse model of hypoxic-ischemic brain injury.

Yu GG; Kim SM; Kim SC; Park GJ; Kim YM; Chai HS; Park HJ; Kim H

Jan 1, 2026Experimental brain research

2026PubMedSupporting evidence

Correlations between cerebrospinal fluid and plasma levels of GABA, glutamate, dopamine, and related metabolites, and their concentrations across neurological disorders.

Deng Y; Wu W; Han S; Jiang H; Guan M

Jan 1, 2026Clinica chimica acta; international journal of clinical chemistry

2026PubMedSupporting evidence

c-Cbl overexpression alleviates pathological damage in Parkinson's disease by suppressing NLRP3 inflammasome-mediated neuroinflammation via the NF-κB signaling pathway.

Bai C; Qi X; Zhu A; Wang A; Zhu Q; Wang C; Liu G; Liu C; Guo Y

Jan 1, 2026Biochimica et biophysica acta. Molecular basis of disease

Page 16 of 30Showing 181-192 of total 358 results.

1...151617...30

Neuroinflammation and immune-brain interactions — Research Evidence and Topic... | Kritoma